CASP3 and cancer: This pyroptosis was achieved by inhibiting the expression of c-myc and mitochondrial hexokinase II (HK-II) in cancer cells, leading to the activation of the BAD/BAX-caspase-3 cascade, and then cleaves GSDME (69).